|
|
Post by jmkopp on Apr 26, 2022 21:21:35 GMT -5
I have followed this company for the last 12 years and find it easy to understand the features and benefits to be vastly superior to the current therapeutic process to use for both type 1 and type 2 diabetics. My niece was recently diagnosed as a type 1. I reached out to her pediatrician as she is 18 and sort of in between a new doctor and her pediatrician. I talked to her about the potential of at least researching a Afrezza as her mealtime insulin along with a CGM. This is the response I got after she "researched" Afrezza.
Only a small percentage of diabetes patients use inhaled insulin because, frankly, it’s not as good as the current advances in pumps 🤷🏻♀️ It is reasonable for certain patients but the general consensus among the endocrinologists I spoke to is that inhaled insulin is not the future of diabetes management. In theory it is reasonable but in actual practical use, for most patients, it isn’t as good as what’s already in use.
I spoke with both adult and peds endocrinologists (altho it’s not approved for use under the age of 18) and it’s not anything they use frequently at all.
I really enjoyed researching this - thanks for giving me an opportunity to learn something new!!!
Hope you’re having a great day!
Again I think that the benefits are very easy to understand. What the hell is wrong with these doctors that they refuse to actually try or at least learn about this innovative treatment.
|
|
|
|
Reality
Apr 26, 2022 21:42:03 GMT -5
Post by stockwhisperer on Apr 26, 2022 21:42:03 GMT -5
Wow, never a dull moment.
And this is an opinion by how many?… And what are their names & titles?… And based on what studies, surveys, facts?… Only a small percentage of diabetes patients use inhaled insulin because, frankly, it’s not as good as the current advances in pumps 🤷🏻♀️ It is reasonable for certain patients but the general consensus among the endocrinologists I spoke to is that inhaled insulin is not the future of diabetes management. In theory it is reasonable but in actual practical use, for most patients, it isn’t as good as what’s already in use.
I spoke with both adult and peds endocrinologists (altho it’s not approved for use under the age of 18) and it’s not anything they use frequently at all.
|
|
|
|
Post by akemp3000 on Apr 26, 2022 21:45:52 GMT -5
Endos and GPs have forever been taught that prescribing insulin is the last resort because of the fear of hypos. This concern is the giant hurdle that will hopefully start to be overcome with pediatric approval. Consider that it would be a narrow perspective to view expensive and complex Bentleys as having advantages over Ford or General Motors automobiles. As Al Mann said, pumps will never become a mainstream solution when you have something as simple and economical to use as Afrezza that can achieve comparable results. Let's hope Al turns out to be right as is usually the case.
|
|
|
|
Post by sportsrancho on Apr 27, 2022 5:04:18 GMT -5
Agree….
And of course it’s true ..like I’ve said before it’s not all about Insurance. This is why Vdex hires their own doctors, yes this is the way they think… why… there are so many reasons why, but personally I would not wanna be locked to a pump day in and day out! It should be very simple but it has to come from the patients. The doctors don’t want to take the time, they don’t get compensated for it. Bill has said this many times …he grew up in a family of doctors, and we deal with this daily, they have to be completely retrained. Look how long it took Ginger!
But the good news is once somebody does take the time and if they’re high profile enough the word will get out. It’s picking up steam now.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 27, 2022 6:02:29 GMT -5
I have followed this company for the last 12 years and find it easy to understand the features and benefits to be vastly superior to the current therapeutic process to use for both type 1 and type 2 diabetics. My niece was recently diagnosed as a type 1. I reached out to her pediatrician as she is 18 and sort of in between a new doctor and her pediatrician. I talked to her about the potential of at least researching a Afrezza as her mealtime insulin along with a CGM. This is the response I got after she "researched" Afrezza. Only a small percentage of diabetes patients use inhaled insulin because, frankly, it’s not as good as the current advances in pumps 🤷🏻♀️ It is reasonable for certain patients but the general consensus among the endocrinologists I spoke to is that inhaled insulin is not the future of diabetes management. In theory it is reasonable but in actual practical use, for most patients, it isn’t as good as what’s already in use. I spoke with both adult and peds endocrinologists (altho it’s not approved for use under the age of 18) and it’s not anything they use frequently at all. I really enjoyed researching this - thanks for giving me an opportunity to learn something new!!! Hope you’re having a great day! Again I think that the benefits are very easy to understand. What the hell is wrong with these doctors that they refuse to actually try or at least learn about this innovative treatment. It's ALL ABOUT THE STUDIES.....Doctors only listen to studies. You need to show them DATA that Afrezza works. Nothing will change until that happens. Salespeople need to get in front of the doctors and DO THEIR JOB! Convince doctors with the DATA! |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 27, 2022 6:03:53 GMT -5
I have followed this company for the last 12 years and find it easy to understand the features and benefits to be vastly superior to the current therapeutic process to use for both type 1 and type 2 diabetics. My niece was recently diagnosed as a type 1. I reached out to her pediatrician as she is 18 and sort of in between a new doctor and her pediatrician. I talked to her about the potential of at least researching a Afrezza as her mealtime insulin along with a CGM. This is the response I got after she "researched" Afrezza. Only a small percentage of diabetes patients use inhaled insulin because, frankly, it’s not as good as the current advances in pumps 🤷🏻♀️ It is reasonable for certain patients but the general consensus among the endocrinologists I spoke to is that inhaled insulin is not the future of diabetes management. In theory it is reasonable but in actual practical use, for most patients, it isn’t as good as what’s already in use. I spoke with both adult and peds endocrinologists (altho it’s not approved for use under the age of 18) and it’s not anything they use frequently at all. I really enjoyed researching this - thanks for giving me an opportunity to learn something new!!! Hope you’re having a great day! Again I think that the benefits are very easy to understand. What the hell is wrong with these doctors that they refuse to actually try or at least learn about this innovative treatment. What did you give the doctor for them to say.....thanks for giving me an opportunity to learn something new!!! |
|
|
|
Post by peppy on Apr 27, 2022 7:13:35 GMT -5
I have followed this company for the last 12 years and find it easy to understand the features and benefits to be vastly superior to the current therapeutic process to use for both type 1 and type 2 diabetics. My niece was recently diagnosed as a type 1. I reached out to her pediatrician as she is 18 and sort of in between a new doctor and her pediatrician. I talked to her about the potential of at least researching a Afrezza as her mealtime insulin along with a CGM. This is the response I got after she "researched" Afrezza. Only a small percentage of diabetes patients use inhaled insulin because, frankly, it’s not as good as the current advances in pumps 🤷🏻♀️ It is reasonable for certain patients but the general consensus among the endocrinologists I spoke to is that inhaled insulin is not the future of diabetes management. In theory it is reasonable but in actual practical use, for most patients, it isn’t as good as what’s already in use. I spoke with both adult and peds endocrinologists (altho it’s not approved for use under the age of 18) and it’s not anything they use frequently at all. I really enjoyed researching this - thanks for giving me an opportunity to learn something new!!! Hope you’re having a great day! Again I think that the benefits are very easy to understand. What the hell is wrong with these doctors that they refuse to actually try or at least learn about this innovative treatment. pretty much the same consensus Stevil has told us about. stevilIn these physicians minds 2 hour peak action of the Rapid acting insulin is better than 30 mins peak action, because, they do not understand blood glucose levels? This is where we are. Physicians that do not care how the patients feel, they just repeat the line. |
|
|
|
Post by stevil on Apr 27, 2022 7:59:31 GMT -5
I don’t think for the vast majority it’s a lack of empathy or interest in their patients. Many are burned out or just have rogue motivations. The vast majority are still well-meaning and compassionate. Of those, you’ll have some that don’t stay current in research.
Long story short, the biggest problem is a lack of data. The newer medications have so much information supporting their use, particularly in the later stages of the disease. Afrezza has none. If you’re going to have a paradigm shift, you cannot rely on old data for insulin but then say, “but this one is different”. Every claim in medicine needs to be supported, particularly when entering a crowded space full of several other well established options.
For Afrezza to really shine, in my opinion, it would be best for MNKD to show trials that early intensive insulin treatment can safely and effectively halt disease progression and prolong complications. That way you have a solo agent being used that physicians feel comfortable with. Plus, they’ll likely be using lower doses of units to remove the “fear factor “. I don’t think this latest dosing study will have much of an effect by itself. If anything, it’ll just be that much more intimidating when a doctor suggests doubling the dose- if you can even convince a doctor to recommend that to their patients. This is going to take a long time to adopt as habits and fears slowly erode over time. It’s a completely different way of approaching the disease. You’re flipping the long-standing protocol on its head. That isn’t going to happen easily or quickly. It will start with the data. No amount of knowledge will replace experience
|
|
|
|
Post by harryx1 on Apr 27, 2022 11:31:43 GMT -5
|
|
|
|
Post by harryx1 on Apr 27, 2022 12:16:14 GMT -5
|
|
|
|
Post by stockwhisperer on Apr 27, 2022 12:21:12 GMT -5
Thanks again Harry (Keeportrade from STs) - great posts, as always. The kind that really matter!
|
|
|
|
Post by robbmo on Apr 27, 2022 12:24:03 GMT -5
I have followed this company for the last 12 years and find it easy to understand the features and benefits to be vastly superior to the current therapeutic process to use for both type 1 and type 2 diabetics. My niece was recently diagnosed as a type 1. I reached out to her pediatrician as she is 18 and sort of in between a new doctor and her pediatrician. I talked to her about the potential of at least researching a Afrezza as her mealtime insulin along with a CGM. This is the response I got after she "researched" Afrezza. Only a small percentage of diabetes patients use inhaled insulin because, frankly, it’s not as good as the current advances in pumps 🤷🏻♀️ It is reasonable for certain patients but the general consensus among the endocrinologists I spoke to is that inhaled insulin is not the future of diabetes management. In theory it is reasonable but in actual practical use, for most patients, it isn’t as good as what’s already in use. I spoke with both adult and peds endocrinologists (altho it’s not approved for use under the age of 18) and it’s not anything they use frequently at all. I really enjoyed researching this - thanks for giving me an opportunity to learn something new!!! Hope you’re having a great day! Again I think that the benefits are very easy to understand. What the hell is wrong with these doctors that they refuse to actually try or at least learn about this innovative treatment. Also, remember, they get paid more if they prescribe an insulin pump. |
|
|
|
Post by boca1girl on Apr 27, 2022 12:54:13 GMT -5
Unfortunately we’ve heard this story many times, pumps are a better treatment approach.
I relayed a story about a recently diagnosed T1 in her late 60’s. I got her interested enough to ask her Endo about it. She participated in a group chat with 10 other patients and her Endo dismissed Afrezza and said the pump was their best treatment option.
“Dump the pump” has not taken hold because of all of the obstacles we’ve faced since FDA approval. It’s still an uphill battle with miles to go yet.
|
|
|
|
Post by stevil on Apr 27, 2022 14:09:35 GMT -5
Unfortunately, the pump has borne out in the data to be the most effective treatment option. Again, until Afrezza goes head to head and proves superiority in high quality studies, nothing is going to significantly change.
|
|
|
|
Post by Clement on Apr 27, 2022 14:35:33 GMT -5
|
|
